CT versus FDG-PET/CT response evaluation in patients with metastatic colorectal cancer treated with irinotecan and cetuximab.
about
Timing and extent of response in colorectal cancer: critical review of current data and implication for future trialsEarly 18F-FDG PET/CT Evaluation Shows Heterogeneous Metabolic Responses to Anti-EGFR Therapy in Patients with Metastatic Colorectal Cancer.Monitoring metabolic response using FDG PET-CT during targeted therapy for metastatic colorectal cancerComparison of the RECIST and PERCIST criteria in solid tumors: a pooled analysis and review.Evaluating tumor response with FDG PET: updates on PERCIST, comparison with EORTC criteria and clues to future developments.Connecting cancer biology and clinical outcomes to imaging in KRAS mutant and wild-type colorectal cancer liver tumors following selective internal radiation therapy with yttrium-90.Early 18F-FDG-PET/CT as a predictive marker for treatment response and survival in patients with metastatic colorectal cancer treated with irinotecan and cetuximab.
P2860
Q26797292-DCDEC9B3-2B99-4343-B23C-CE52205953F7Q36022493-C317A8FF-6575-46ED-B5CB-7C31935268B8Q37143791-4FB9ACBA-BC98-4639-A035-D595A50EB83FQ37317418-AE6E03D8-C722-4685-A657-6E3A83284F88Q38737416-CF42CBCE-C8CF-454B-A2C2-32E018843ABBQ38947677-26CD8B54-46FB-4C84-9439-A207DB79A14FQ53580110-FA5521D7-4D08-4C99-BA36-6F72CD105E88
P2860
CT versus FDG-PET/CT response evaluation in patients with metastatic colorectal cancer treated with irinotecan and cetuximab.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
CT versus FDG-PET/CT response ...... with irinotecan and cetuximab.
@ast
CT versus FDG-PET/CT response ...... with irinotecan and cetuximab.
@en
CT versus FDG-PET/CT response ...... with irinotecan and cetuximab.
@nl
type
label
CT versus FDG-PET/CT response ...... with irinotecan and cetuximab.
@ast
CT versus FDG-PET/CT response ...... with irinotecan and cetuximab.
@en
CT versus FDG-PET/CT response ...... with irinotecan and cetuximab.
@nl
prefLabel
CT versus FDG-PET/CT response ...... with irinotecan and cetuximab.
@ast
CT versus FDG-PET/CT response ...... with irinotecan and cetuximab.
@en
CT versus FDG-PET/CT response ...... with irinotecan and cetuximab.
@nl
P2093
P2860
P356
P1433
P1476
CT versus FDG-PET/CT response ...... with irinotecan and cetuximab.
@en
P2093
Benny Vittrup Jensen
Dorte Nielsen
Helle Hjorth Johannesen
Helle Westergren Hendel
Jakob Vasehus Schou
Kristin Skougaard
P2860
P304
P356
10.1002/CAM4.271
P407
P577
2014-06-18T00:00:00Z